Back

Does symptom profile modify revascularization benefit in ischemic LV dysfunction? A win ratio analysis pooling STICHES and REVIVED-BCIS2

31 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: From infarction to recovery: SGLT2 and rehabilitation in heart failure Multidisciplinary Interventions ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Guangyu Tong

Yale School of Medicine, New Haven (United States of America)

6 More presentations in this session

Presentation thumbnail
Dapagliflozin attenuates post-infarction inflammation and remodeling via promoting metabolic reprogramming–driven cardiac lymphangiogenesis
Doctor Z. Zhang (CN)
Abstract
Presentation thumbnail
Heart failure therapy optimization in myocardial infarction patients with systolic dysfunction during Phase 2 and 3 Cardiac Rehabilitation
Doctor S. Cardona Tercero (Valencia, ES)
Abstract
Presentation thumbnail
Effects of beta-blocker treatment on circulating biomarkers of fibrosis in patients with myocardial infarction without heart failure: A substudy of the BETAMI-DANBLOCK trial
Professor I. Lunde (Oslo, NO)
Abstract
Presentation thumbnail
Differences in survival outcomes and LVEF of self-expanding versus balloon expandable valves after TAVI in patients with severe cardiac dysfunction
Doctor A. Matta (Toulouse, FR)
Abstract
Presentation thumbnail
Reversal of residual left ventricular remodeling in corrected primary valvular regurgitation: is it different from dilated cardiomyopathy
Mr R. Zhang (Chengdu, CN)
Abstract

Access the full session

Session thumbnail
From infarction to recovery: SGLT2 and rehabilitation in heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Coronary revascularization for patients with heart failure and coronary artery disease: a systematic review and meta-analysis of randomized trials
22 May 2023
thumbnail
Congress Presentation
Impact of baseline surgical risk on the treatment effect of PCI and CABG in ischemic left ventricular systolic dysfunction: results of the REVIVED-BCIS2 and STICH randomized controlled trials
2 September 2024
thumbnail
Congress Presentation
Predicting responderity for cardiac resynchronization therapy in patients with heart failure with reduced ejection fraction using novel myocardial work analysis: A single center pilot study
22 May 2023
thumbnail
Congress Presentation
A further update on symptom clusters among patients with heart failure: a systematic review and meta-analysis
24 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources